| Filed On | Filing |
|---|---|
| 08 Sep 2026 | SCHEDULE 13D/A |
| 08 Sep 2026 |
Form 4: Moroun Matthew T, Director
Sold 3,268,000 shares ($31.2M) · Bought 3,268,000 shares ($31.2M) |
| 07 Aug 2026 | FORM 10-Q |
| 05 Aug 2026 |
Form 4: Kleine Daniel C., SVP of Fin., CFO & Treasurer
Received 20,000 shares as a grant or award |
| 04 Aug 2026 | 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation |
| 12 May 2026 |
Form 4: Moroun Matthew T, Director
Received 1,453 shares as a grant or award ($15K) |
| 12 May 2026 |
Form 4: Moroun Matthew J., Director
Received 1,453 shares as a grant or award ($15K) |
| 12 May 2026 |
Form 4: Mclarty Franklin, Director
Received 484 shares as a grant or award ($4.99K) |
| 12 May 2026 |
Form 4: Bishop Michael D., Director
Received 968 shares as a grant or award ($9.99K) |
| 08 May 2026 | FORM 10-Q |
| 05 May 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 01 May 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 27 Mar 2026 |
Proxy statement: annual meeting on April 30, 2026
CEO pay $2.1M, up 344% · say-on-pay vote |
| 12 Mar 2026 | FORM 10-K |
| 19 Feb 2026 | 8-K: Results of Operations and Financial Condition |
| 11 Feb 2026 |
Form 4: Stewart Lance, Director
Gave up 11,354 shares to cover exercise price or tax ($137K) |
| 05 Nov 2025 | FORM 10-Q |
| 31 Oct 2025 | 8-K: Results of Operations and Financial Condition |
| 15 Sep 2025 | SCHEDULE 13D/A |
| 15 Sep 2025 |
Form 4: Moroun Matthew T, Director
Sold 2,000,000 shares ($21.5M) · Bought 2,000,000 shares ($21.5M) |
Loading...